JESSICA SMITH: Open Payments
NPI 1215707187 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $186 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Tempus AI, Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: QULIPTA, PREVNAR 20, UBRELVY, MOUNJARO, AIRSUPRA, ZEPZELCA, XT CDX, ELIQUIS.
Industry payments across FL — which companies pay providers there.
